Part of a comprehensive analysis of the Medicines Act 1975
All Parts in This Series
Analysis of Part 6: Miscellaneous and Supplementary Provisions of the Medicines Act 1975
The Medicines Act 1975 (the “Act”) contains a comprehensive set of provisions aimed at regulating medicinal products and related substances in Singapore. Part 6 of the Act, titled “Miscellaneous and Supplementary Provisions,” encompasses sections 54 to 77. These provisions serve as the backbone for the administration, enforcement, and interpretation of the Act, ensuring its effective operation and integration with other laws. This analysis explores the key provisions, their purposes, penalties for non-compliance, definitions, and cross-references to other legislation.
Key Provisions and Their Purpose
Part 6 of the Medicines Act 1975 is designed to provide the Minister and enforcement authorities with broad powers to regulate substances and articles that may not strictly be medicinal products but are used for medicinal or cosmetic purposes. It also establishes procedural safeguards, enforcement mechanisms, and administrative frameworks to support the Act’s objectives.
"PART 6 MISCELLANEOUS AND SUPPLEMENTARY PROVISIONS" and sections 54 to 77 describe various powers, offences, procedures, and administrative provisions to support the Act's operation. — Part 6, Medicines Act 1975
Verify source in source document →
The key provisions include:
- Section 54: Empowers the Minister to specify articles or substances that are not medicinal products but are used for medicinal or cosmetic purposes. The Minister may apply any provisions of the Act to these articles or substances. This provision exists to capture products that, while not strictly medicines, have effects or uses that warrant regulatory oversight to protect public health.
- Section 55: Similar to section 54, this section allows the Minister to specify substances that are not medicinal products but are used as ingredients or are dangerous. The Act’s provisions can then be applied to these substances. This ensures that potentially harmful substances are regulated even if they do not fall within the traditional definition of medicinal products.
- Sections 56 to 58: These sections grant rights of entry, inspection, sampling, and seizure to authorised officers. They also impose penalties for wilful obstruction or failure to comply with lawful requirements. These powers are essential for enforcement and compliance monitoring, enabling authorities to investigate and act against breaches effectively.
- Sections 59 to 61: Provide for the seizure, detention, forfeiture, and disposal of goods that contravene the Act. These provisions protect consumers by removing unsafe or unapproved products from circulation.
- Sections 62 to 67: Address restrictions on disclosure of information obtained under the Act, protection for officers acting in good faith, offences by bodies corporate, defences available to accused persons, and warranties relating to medicinal products. These provisions balance enforcement with fairness and confidentiality.
- Sections 68 to 69: Deal with evidentiary matters and presumptions in legal proceedings under the Act, facilitating efficient prosecution and adjudication.
- Sections 70 to 72A: Cover procedural aspects such as service of documents, jurisdiction of courts, composition of offences, and payment of fees. These ensure smooth administrative and judicial processes.
- Sections 73 to 74: Establish advisory committees to assist the Minister and empower the Minister to make regulations, including prescribing offences and penalties. This allows for expert input and flexibility in regulatory responses.
- Sections 75 to 77: Clarify the relationship of the Medicines Act with other laws, repeal obsolete provisions, and exclude health products regulated under the Health Products Act 2007 from the Medicines Act’s scope. This prevents regulatory overlap and confusion.
Overall, these provisions exist to ensure that the Medicines Act remains adaptable, enforceable, and consistent with Singapore’s broader legal framework, thereby safeguarding public health and safety.
Definitions in Part 6
Part 6 contains minimal explicit definitions, reflecting its supplementary nature. The only explicit definition is found in section 54(3), which defines the term “cosmetic.” This definition is crucial because section 54 empowers the Minister to regulate articles used for cosmetic purposes under the Act.
"In this section, 'cosmetic' means any article intended to be rubbed, poured, sprinkled or sprayed on, or introduced into, or otherwise applied to, the human body or any part thereof for cleansing, beautifying, promoting attractiveness or altering the appearance, and includes a deodorant or any depilatory substance but does not include a soap." — Section 54(3), Medicines Act 1975
Verify Section 54 in source document →
This definition exists to delineate the scope of products subject to regulation under section 54. By excluding soap, the Act avoids regulating everyday cleansing agents that do not pose significant medicinal or cosmetic risks, focusing instead on products with a more direct impact on appearance or health.
Penalties for Non-Compliance
The Act prescribes a range of penalties to deter non-compliance and ensure enforcement. These penalties vary depending on the nature and severity of the offence, reflecting the importance of compliance in protecting public health.
"(2) Any person who wilfully obstructs... shall be guilty of an offence and shall be liable on conviction to a fine not exceeding $2,000." "(3) ...makes any statement which the person knows to be false, the person shall be guilty of an offence and shall be liable on conviction to a fine not exceeding $5,000 or to imprisonment for a term not exceeding 2 years or to both." — Section 58(2) and (3), Medicines Act 1975
Verify Section 58 in source document →
"(2) Any person guilty of an offence under this section shall be liable on conviction to a fine not exceeding $5,000 or to imprisonment for a term not exceeding 2 years or to both." — Section 62(2), Medicines Act 1975
Verify Section 62 in source document →
"(3) Any person guilty of an offence under this section shall be liable on conviction to a fine not exceeding $5,000 or to imprisonment for a term not exceeding 2 years or to both." — Section 66(3), Medicines Act 1975
Verify Section 66 in source document →
"(d) provide that any person who contravenes the regulations shall be guilty of an offence and shall be liable on conviction to a fine not exceeding $5,000 or to imprisonment for a term not exceeding 2 years or to both." — Section 74(2)(d), Medicines Act 1975
Verify Section 74 in source document →
Specifically:
- Section 58(2): Imposes a fine up to $2,000 for wilful obstruction of authorised officers or failure to comply with lawful requirements. This penalty exists to ensure that enforcement officers can carry out their duties without hindrance.
- Section 58(3): Provides for a fine up to $5,000 and/or imprisonment up to 2 years for knowingly giving false information. This severe penalty deters dishonesty that could undermine regulatory processes.
- Section 62(2): Penalises unlawful disclosure of information with fines and imprisonment, protecting confidentiality and integrity of investigations.
- Section 66(3): Addresses offences related to warranties on medicinal products, ensuring truthful representations to consumers.
- Section 74(2)(d): Allows the Minister to prescribe offences and penalties for contravention of regulations, providing flexibility to address emerging issues.
These penalties collectively uphold the Act’s enforcement regime, ensuring compliance and protecting public health interests.
Cross-References to Other Acts
The Medicines Act recognises the importance of harmonising with other legislation to avoid duplication and conflict. Several provisions explicitly cross-reference other laws, clarifying the Act’s relationship within Singapore’s legal framework.
"Except as expressly provided in this Act, this Act does not limit or affect in any way the provisions or operation of any other written law relating to any matter which may be dealt with in this Act." — Section 75, Medicines Act 1975
Verify Section 75 in source document →
"The Poisons Act 1938 is amended in the manner set out in the Second Schedule." — Section 76(2), Medicines Act 1975
Verify Section 76 in source document →
"Where any product to which this Act applies has been categorised as a type of health product under the Health Products Act 2007, the Minister may... declare that the provisions of this Act cease to apply to that type of product..." — Section 77(1), Medicines Act 1975
Verify Section 77 in source document →
"All fees... must be paid... to the National Parks Board established by the repealed National Parks Act (Cap. 198A, 1991 Revised Edition) as in force before 1 July 1996 and continued by section 3 of the National Parks Board Act 1996." — Section 72A(b), Medicines Act 1975
Verify Section 72A in source document →
These cross-references serve several purposes:
- Section 75: Ensures that the Medicines Act does not override or limit other written laws unless expressly stated. This preserves the integrity of Singapore’s broader legal system and prevents regulatory conflicts.
- Section 76(2): Amends the Poisons Act 1938, reflecting the interconnectedness of medicinal and poisonous substances regulation.
- Section 77: Excludes health products regulated under the Health Products Act 2007 from the Medicines Act’s scope, preventing overlapping regulation and clarifying jurisdiction.
- Section 72A(b): References the National Parks Board for fee payments, illustrating administrative continuity despite legislative changes.
These provisions demonstrate the Act’s integration with Singapore’s legislative ecosystem, facilitating coherent and effective regulation.
Conclusion
Part 6 of the Medicines Act 1975 is a critical component that underpins the Act’s regulatory framework. By empowering the Minister to regulate a broad range of substances, establishing enforcement powers, prescribing penalties, and ensuring harmonious interaction with other laws, these miscellaneous and supplementary provisions ensure the Act’s robustness and adaptability. The clear definitions, procedural safeguards, and penalties reflect a balanced approach to protecting public health while providing administrative clarity and legal certainty.
Sections Covered in This Analysis
- Section 54 – Minister’s power to specify articles or substances for regulation
- Section 55 – Minister’s power to specify dangerous substances or ingredients
- Sections 56 to 58 – Rights of entry, inspection, sampling, seizure, and penalties for obstruction
- Sections 59 to 61 – Seizure, detention, forfeiture, and disposal of goods
- Sections 62 to 67 – Restrictions on disclosure, protection for officers, offences by bodies corporate, defences, and warranties
- Sections 68 to 69 – Evidence and presumptions in proceedings
- Sections 70 to 72A – Service of documents, jurisdiction, composition of offences, and payment of fees
- Sections 73 to 74 – Advisory committees and regulations
- Sections 75 to 77 – Application of other laws, repeal, and non-application to health products under Health Products Act 2007
Source Documents
For the authoritative text, consult SSO.